+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899476
Description Jump to:
The global multiomics market size is expected to reach USD 6.38 billion by 2030, registering a CAGR of 15.3% from 2023 to 2030. Factors such as the decreasing costs of omics technologies and growing investment and funding from private and public players are expected to drive the market. In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period.

With the improvement in technologies, the cost of omics technologies is anticipated to reduce, which can increase the accessibility of datasets to researchers, consequently driving market growth. Companies are focusing on technological advancements to lower costs. For instance, in November 2022, Amazon Web Services introduced an Amazon Omics service. This service utilizes bioinformatics-aware storage options to store raw sequence data and to decrease costs. Thus, the decreasing costs are anticipated to increase the accessibility of omics technologies to researchers and clinicians. Such cost reduction is expected to increase the adoption of multiomics approaches.

The growing investments and funding from private and public participants are anticipated to boost the demand for multi-omics products and services. Various companies are significantly investing in the development of multiomics platforms and technologies. For instance, in January 2022, Roche invested USD 290 million in Freenome, a biotech company. This investment was used to accelerate multiomics platforms for early cancer detection. In addition, in May 2023, MultiOmic Health completed a funding round of USD 6.2 million to construct a precision therapeutics discovery platform. Thus, the rising funding and investments are expected to develop various novel platforms and products in the markets

The rising emphasis of market players to develop innovative products and services is another vital factor propelling market demand forward. Various companies are developing novel platforms to sustain the rising competition. For instance, in February 2023, Via Scientific, Inc. introduced a multi-omics accelerator platform, Foundry, that supports the automation of complex data and analytical work during multi-omics research. Such product launches are anticipated to drive the industry over the forecast period.

Multiomics Market Report Highlights

  • Based on product & service, the product segment dominated the market with a revenue share of 60.5% in 2022, which can be attributed to the rising launches of products such as instruments and software
  • Based on type, the bulk multiomics held the largest revenue contributor for the industry. In contrast, single-cell multi-omics is expected to grow at the fastest CAGR of 17.8% over the forecast period, due to increasing demand for single-cell multi-omics to comprehend complex biology systems
  • Based on platform, genomics dominated the market with a revenue share of 40.6% in 2022. The growth is attributed to the high number of products available in this segment
  • Based on application, the cell biology segment dominated the global industry with a share of 38.8% in 2022. In contrast, the oncology segment is projected to register the highest growth rate during the projected period
  • Based on end-use, the academic and research institute segment was the largest revenue contributor for the industry, with a share of 50.7%. In contrast, pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to increasing demand for multi-omics to accelerate drug discovery and development
  • North America dominated the global industry in 2022 with a revenue share of 48.45%, owing to the presence of key market players in the region


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Platform & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Platform & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing demand for single cell omics
3.2.1.2. Advancements in omics technology and decreasing costs of omics technologies
3.2.1.3. Increasing investments and funding from private and public players
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges in multiomics data integration and data complexity
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product & Service Business Analysis
4.1. Multiomics Market: Product & Service Movement Analysis
4.2. Products
4.2.1. Products Market, 2018 - 2030 (USD Million)
4.2.2. Instruments
4.2.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.2.3. Consumables
4.2.3.1. Consumables Market, 2018 - 2030 (USD Million)
4.2.4. Software
4.2.4.1. Software Market, 2018 - 2030 (USD Million)
4.3. Services
4.3.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Type Business Analysis
5.1. Multiomics Market: Type Movement Analysis
5.2. Single- Cell Multiomics
5.2.1. Single- Cell Multiomics Market, 2018 - 2030 (USD Million)
5.3. Bulk Multiomics
5.3.1. Bulk Multiomics Market, 2018 - 2030 (USD Million)
Chapter 6. Platform Business Analysis
6.1. Multiomics Market: Platform Movement Analysis
6.2. Genomics
6.2.1. Genomics Market, 2018 - 2030 (USD Million)
6.3. Transcriptomics
6.3.1. Transcriptomics Market, 2018 - 2030 (USD Million)
6.4. Proteomics
6.4.1. Proteomics Market, 2018 - 2030 (USD Million)
6.5. Metabolomics
6.5.1. Metabolomics Market, 2018 - 2030 (USD Million)
6.6. Integrated Omics Platforms
6.6.1. Integrated Omics Platforms Market, 2018 - 2030 (USD Million)
Chapter 7. Application Business Analysis
7.1. Multiomics Market: Application Movement Analysis
7.2. Cell Biology
7.2.1. Cell Biology Market, 2018 - 2030 (USD Million)
7.3. Oncology
7.3.1. Oncology Market, 2018 - 2030 (USD Million)
7.4. Neurology
7.4.1. Neurology Market, 2018 - 2030 (USD Million)
7.5. Immunology
7.5.1. Immunology Market, 2018 - 2030 (USD Million)
Chapter 8. End-use Business Analysis
8.1. Multiomics Market: End-use Movement Analysis
8.2. Academic and Research Institutes
8.2.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
8.3. Pharmaceutical & Biotechnology Companies
8.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
8.4. Others
8.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Multiomics Market Share By Region, 2022 & 2030
9.2. North America
9.2.1. North America Multiomics Market, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Target Disease Prevalence
9.2.2.3. Competitive Scenario
9.2.2.4. U.S. Multiomics Market, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. Canada Multiomics Market, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe Multiomics Market, 2018 - 2030 (USD Million)
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Target Disease Prevalence
9.3.2.3. Competitive Scenario
9.3.2.4. UK Multiomics Market, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Germany Multiomics Market, 2018 - 2030 (USD Million)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. France Multiomics Market, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Competitive Scenario
9.3.5.4. Italy Multiomics Market, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Competitive Scenario
9.3.6.4. Spain Multiomics Market, 2018 - 2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Competitive Scenario
9.3.7.4. Denmark Multiomics Market, 2018 - 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Competitive Scenario
9.3.8.4. Sweden Multiomics Market, 2018 - 2030 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Competitive Scenario
9.3.9.4. Norway Multiomics Market, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Multiomics Market, 2018 - 2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Target Disease Prevalence
9.4.2.3. Competitive Scenario
9.4.2.4. Japan Multiomics Market, 2018 - 2030 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. China Multiomics Market, 2018 - 2030 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. India Multiomics Market, 2018 - 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Australia Multiomics Market, 2018 - 2030 (USD Million)
9.4.6. Thailand
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Thailand Multiomics Market, 2018 - 2030 (USD Million)
9.4.7. South Korea
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. South Korea Multiomics Market, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Multiomics Market, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Target Disease Prevalence
9.5.2.3. Competitive Scenario
9.5.2.4. Brazil Multiomics Market, 2018 - 2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Mexico Multiomics Market, 2018 - 2030 (USD Million)
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. Argentina Multiomics Market, 2018 - 2030 (USD Million)
9.6. MEA
9.6.1. MEA Multiomics Market, 2018 - 2030 (USD Million)
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. Target Disease Prevalence
9.6.2.3. Competitive Scenario
9.6.2.4. South Africa Multiomics Market, 2018 - 2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Saudi Arabia Multiomics Market, 2018 - 2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Competitive Scenario
9.6.4.4. UAE Multiomics Market, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Competitive Scenario
9.6.5.4. Kuwait Multiomics Market, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2022
10.4. Company Profiles/Listing
10.4.1. BD
10.4.1.1. Overview
10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Thermo Fisher Scientific, Inc,
10.4.2.1. Overview
10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Illumina
10.4.3.1. Overview
10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. Danaher
10.4.4.1. Overview
10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. PerkinElmer
10.4.5.1. Overview
10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Shimadzu Corporation
10.4.6.1. Overview
10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. Bruker
10.4.7.1. Overview
10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. QIAGEN
10.4.8.1. Overview
10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. Agilent Technologies
10.4.9.1. Overview
10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. BGI
10.4.10.1. Overview
10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 4 Global Multiomics Market, By Type, 2018-2030 (USD Million)
Table 5 Global Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 6 Global Multiomics Market, By Application, 2018-2030 (USD Million)
Table 7 Global Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 8 Global Multiomics Market, By Region, 2018-2030 (USD Million)
Table 9 North America Multiomics Market, By Country, 2018-2030 (USD Million)
Table 10 North America Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 11 North America Multiomics Market, By Type, 2018-2030 (USD Million)
Table 12 North America Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 13 North America Multiomics Market, By Application, 2018-2030 (USD Million)
Table 14 North America Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 15 U.S. Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 16 U.S. Multiomics Market, By Type, 2018-2030 (USD Million)
Table 17 U.S. Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 18 U.S. Multiomics Market, By Application, 2018-2030 (USD Million)
Table 19 U.S. Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 20 Canada Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 21 Canada Multiomics Market, By Type, 2018-2030 (USD Million)
Table 22 Canada Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 23 Canada Multiomics Market, By Application, 2018-2030 (USD Million)
Table 24 Canada Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 25 Europe Multiomics Market, By Country, 2018-2030 (USD Million)
Table 26 Europe Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 27 Europe Multiomics Market, By Type, 2018-2030 (USD Million)
Table 28 Europe Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 29 Europe Multiomics Market, By Application, 2018-2030 (USD Million)
Table 30 Europe Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 31 UK Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 32 UK Multiomics Market, By Type, 2018-2030 (USD Million)
Table 33 UK Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 34 UK Multiomics Market, By Application, 2018-2030 (USD Million)
Table 35 UK Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 36 Germany Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 37 Germany Multiomics Market, By Type, 2018-2030 (USD Million)
Table 38 Germany Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 39 Germany Multiomics Market, By Application, 2018-2030 (USD Million)
Table 40 Germany Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 41 France Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 42 France Multiomics Market, By Type, 2018-2030 (USD Million)
Table 43 France Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 44 France Multiomics Market, By Application, 2018-2030 (USD Million)
Table 45 France Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 46 Spain Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 47 Spain Multiomics Market, By Type, 2018-2030 (USD Million)
Table 48 Spain Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 49 Spain Multiomics Market, By Application, 2018-2030 (USD Million)
Table 50 Spain Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 51 Italy Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 52 Italy Multiomics Market, By Type, 2018-2030 (USD Million)
Table 53 Italy Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 54 Italy Multiomics Market, By Application, 2018-2030 (USD Million)
Table 55 Italy Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 56 Denmark Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 57 Denmark Multiomics Market, By Type, 2018-2030 (USD Million)
Table 58 Denmark Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 59 Denmark Multiomics Market, By Application, 2018-2030 (USD Million)
Table 60 Denmark Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 61 Norway Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 62 Norway Multiomics Market, By Type, 2018-2030 (USD Million)
Table 63 Norway Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 64 Norway Multiomics Market, By Application, 2018-2030 (USD Million)
Table 65 Norway Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 66 Sweden Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 67 Sweden Multiomics Market, By Type, 2018-2030 (USD Million)
Table 68 Sweden Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 69 Sweden Multiomics Market, By Application, 2018-2030 (USD Million)
Table 70 Sweden Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 71 Asia Pacific Multiomics Market, By Country, 2018-2030 (USD Million)
Table 72 Asia Pacific Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 73 Asia Pacific Multiomics Market, By Type, 2018-2030 (USD Million)
Table 74 Asia Pacific Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 75 Asia Pacific Multiomics Market, By Application, 2018-2030 (USD Million)
Table 76 Asia Pacific Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 77 China Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 78 China Multiomics Market, By Type, 2018-2030 (USD Million)
Table 79 China Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 80 China Multiomics Market, By Application, 2018-2030 (USD Million)
Table 81 China Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 82 Japan Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 83 Japan Multiomics Market, By Type, 2018-2030 (USD Million)
Table 84 Japan Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 85 Japan Multiomics Market, By Application, 2018-2030 (USD Million)
Table 86 Japan Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 87 India Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 88 India Multiomics Market, By Type, 2018-2030 (USD Million)
Table 89 India Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 90 India Multiomics Market, By Application, 2018-2030 (USD Million)
Table 91 India Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 92 South Korea Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 93 South Korea Multiomics Market, By Type, 2018-2030 (USD Million)
Table 94 South Korea Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 95 South Korea Multiomics Market, By Application, 2018-2030 (USD Million)
Table 96 South Korea Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 97 Australia Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 98 Australia Multiomics Market, By Type, 2018-2030 (USD Million)
Table 99 Australia Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 100 Australia Multiomics Market, By Application, 2018-2030 (USD Million)
Table 101 Australia Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 102 Thailand Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 103 Thailand Multiomics Market, By Type, 2018-2030 (USD Million)
Table 104 Thailand Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 105 Thailand Multiomics Market, By Application, 2018-2030 (USD Million)
Table 106 Thailand Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 107 Latin America Multiomics Market, By Country, 2018-2030 (USD Million)
Table 108 Latin America Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 109 Latin America Multiomics Market, By Type, 2018-2030 (USD Million)
Table 110 Latin America Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 111 Latin America Multiomics Market, By Application, 2018-2030 (USD Million)
Table 112 Latin America Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 113 Brazil Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 114 Brazil Multiomics Market, By Type, 2018-2030 (USD Million)
Table 115 Brazil Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 116 Brazil Multiomics Market, By Application, 2018-2030 (USD Million)
Table 117 Brazil Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 118 Mexico Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 119 Mexico Multiomics Market, By Type, 2018-2030 (USD Million)
Table 120 Mexico Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 121 Mexico Multiomics Market, By Application, 2018-2030 (USD Million)
Table 122 Mexico Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 123 Argentina Multiomics Market, By Product & Service, 2018-2030 (USD Million),
Table 124 Argentina Multiomics Market, By Type, 2018-2030 (USD Million)
Table 125 Argentina Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 126 Argentina Multiomics Market, By Application, 2018-2030 (USD Million)
Table 127 Argentina Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 128 MEA Multiomics Market, By Country, 2018-2030 (USD Million)
Table 129 MEA Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 130 MEA Multiomics Market, By Type, 2018-2030 (USD Million)
Table 131 MEA Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 132 MEA Multiomics Market, By Application, 2018-2030 (USD Million)
Table 133 MEA Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 134 South Africa Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 135 South Africa Multiomics Market, By Type, 2018-2030 (USD Million)
Table 136 South Africa Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 137 South Africa Multiomics Market, By Application, 2018-2030 (USD Million)
Table 138 South Africa Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 139 UAE Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 140 UAE Multiomics Market, By Type, 2018-2030 (USD Million)
Table 141 UAE Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 142 UAE Multiomics Market, By Application, 2018-2030 (USD Million)
Table 143 UAE Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 144 Saudi Arabia Multiomics Market, By Product & Service, 2018-2030 (USD Million),
Table 145 Saudi Arabia Multiomics Market, By Type, 2018-2030 (USD Million)
Table 146 Saudi Arabia Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 147 Saudi Arabia Multiomics Market, By Application, 2018-2030 (USD Million)
Table 148 Saudi Arabia Multiomics Market, By End-use, 2018-2030 (USD Million)
Table 149 Kuwait Multiomics Market, By Product & Service, 2018-2030 (USD Million)
Table 150 Kuwait Multiomics Market, By Type, 2018-2030 (USD Million)
Table 151 Kuwait Multiomics Market, By Platform, 2018-2030 (USD Million)
Table 152 Kuwait Multiomics Market, By Application, 2018-2030 (USD Million)
Table 153 Kuwait Multiomics Market, By End-use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Multiomics market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Global multiomics market: Product & Service outlook and key takeaways
Fig. 15 Global multiomics market: Product & Service movement analysis
Fig. 16 Global multiomics market, for products, 2018-2030 (USD Million)
Fig. 17 Global multiomics market, for instruments, 2018-2030 (USD Million)
Fig. 18 Global multiomics market, for consumables, 2018-2030 (USD Million)
Fig. 19 Global multiomics market, for software, 2018-2030 (USD Million)
Fig. 20 Global multiomics market, for services, 2018-2030 (USD Million)
Fig. 21 Global multiomics market: Type outlook and key takeaways
Fig. 22 Global multiomics market: Type movement analysis
Fig. 23 Global multiomics market, for single- cell multiomics, 2018-2030 (USD Million)
Fig. 24 Global multiomics market, for bulk multiomics, 2018-2030 (USD Million)
Fig. 25 Global multiomics market: Platform outlook and key takeaways
Fig. 26 Global multiomics market: Platform movement analysis
Fig. 27 Global multiomics market, for genomics, 2018-2030 (USD Million)
Fig. 28 Global multiomics market, for transcriptomics, 2018-2030 (USD Million)
Fig. 29 Global multiomics market, for proteomics, 2018-2030 (USD Million)
Fig. 30 Global multiomics market, for metabolomics, 2018-2030 (USD Million)
Fig. 31 Global multiomics market, for integrated omics platforms, 2018-2030 (USD Million)
Fig. 32 Global multiomics market: Application outlook and key takeaways
Fig. 33 Global multiomics market: Application movement analysis
Fig. 34 Global multiomics market, for cell biology, 2018-2030 (USD Million)
Fig. 35 Global multiomics market, for oncology, 2018-2030 (USD Million)
Fig. 36 Global multiomics market, for neurology, 2018-2030 (USD Million)
Fig. 37 Global multiomics market, for immunology, 2018-2030 (USD Million)
Fig. 38 Global multiomics market: End-use outlook and key takeaways
Fig. 39 Global multiomics market: End-use movement analysis
Fig. 40 Global multiomics market, for academic and research institutes, 2018-2030 (USD Million)
Fig. 41 Global multiomics market, for pharmaceutical & biotechnology companies, 2018-2030 (USD Million)
Fig. 42 Global multiomics market, for others, 2018-2030 (USD Million)
Fig. 43 Regional marketplace: Key takeaways
Fig. 44 Regional outlook, 2022 & 2030
Fig. 45 Global multiomics market: Region movement analysis
Fig. 46 North America multiomics market, 2018-2030 (USD Million)
Fig. 47 U.S. multiomics market, 2018-2030 (USD Million)
Fig. 48 Canada multiomics market, 2018-2030 (USD Million)
Fig. 49 Europe multiomics market, 2018-2030 (USD Million)
Fig. 50 Germany multiomics market, 2018-2030 (USD Million)
Fig. 51 UK multiomics market, 2018-2030 (USD Million)
Fig. 52 France multiomics market, 2018-2030 (USD Million)
Fig. 53 Italy multiomics market, 2018-2030 (USD Million)
Fig. 54 Spain multiomics market, 2018-2030 (USD Million)
Fig. 55 Denmark multiomics market, 2018-2030 (USD Million)
Fig. 56 Sweden multiomics market, 2018-2030 (USD Million)
Fig. 57 Norway multiomics market, 2018-2030 (USD Million)
Fig. 58 Asia Pacific multiomics market, 2018-2030 (USD Million)
Fig. 59 Japan multiomics market, 2018-2030 (USD Million)
Fig. 60 China multiomics market, 2018-2030 (USD Million)
Fig. 61 India multiomics market, 2018-2030 (USD Million)
Fig. 62 Australia multiomics market, 2018-2030 (USD Million)
Fig. 63 South Korea multiomics market, 2018-2030 (USD Million)
Fig. 64 Thailand multiomics market, 2018-2030 (USD Million)
Fig. 65 Latin America multiomics market, 2018-2030 (USD Million)
Fig. 66 Brazil multiomics market, 2018-2030 (USD Million)
Fig. 67 Mexico multiomics market, 2018-2030 (USD Million)
Fig. 68 Argentina multiomics market, 2018-2030 (USD Million)
Fig. 69 Middle East and Africa multiomics market, 2018-2030 (USD Million)
Fig. 70 South Africa multiomics market, 2018-2030 (USD Million)
Fig. 71 Saudi Arabia multiomics market, 2018-2030 (USD Million)
Fig. 72 UAE multiomics market, 2018-2030 (USD Million)
Fig. 73 Kuwait multiomics market, 2018-2030 (USD Million)

Companies Mentioned

  • BD
  • Thermo Fisher Scientific, Inc,
  • Illumina
  • Danaher
  • PerkinElmer
  • Shimadzu Corporation
  • Bruker
  • QIAGEN
  • Agilent Technologies
  • BGI

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedOctober 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 2.03 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.38 Billion
Compound Annual Growth Rate15.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Multiomics Market by Product (Consumables, Instrument, Software), Type (Epigenomics, Genomics, Metabolomics), Application, End-User - Forecast 2024-2030 - Product Image

Global Multiomics Market by Product (Consumables, Instrument, Software), Type (Epigenomics, Genomics, Metabolomics), Application, End-User - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Global Multiomics Market Analysis & Forecast to 2024-2034 - Product Image

Global Multiomics Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Global Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
Biotechnology Instruments Market Size, Share & Trends Analysis Report By Product (Cell Culture Instruments, Analytical Instruments), By End-use (Pharma & Biotech Companies, Academic & Research Institutes), And Segment Forecasts, 2023 - 2030 - Product Image

Biotechnology Instruments Market Size, Share & Trends Analysis Report By Product (Cell Culture Instruments, Analytical Instruments), By End-use (Pharma & Biotech Companies, Academic & Research Institutes), And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Cell-based Assay Market Report by Product and Services, Technology, Application, End-User, and Region 2024-2032 - Product Image

Cell-based Assay Market Report by Product and Services, Technology, Application, End-User, and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.